Share this Article
Shih CJ, Tarng DC, Yang WC, Yang CY
Correspondence: Dr Chih-Yu Yang, cyyang3@vghtpe.gov.tw
ABSTRACT
INTRODUCTION Due to lifelong immunosuppression, renal transplant recipients (RTRs) are at risk of infectious complications such as pneumonia. Severe pneumonia results in respiratory failure and is life?threatening. We aimed to examine the influence of immunosuppressant dose reduction on RTRs with bacterial pneumonia and respiratory failure.
METHODS From January 2001 to January 2011, 33 of 1,146 RTRs at a single centre developed bacterial pneumonia with respiratory failure. All patients were treated using mechanical ventilation and aggressive therapies in the intensive care unit.
RESULTS Average time from kidney transplantation to pneumonia with respiratory failure was 6.8 years. In-hospital mortality rate was 45.5% despite intensive care and aggressive therapies. Logistic regression analysis indicated that a high serum creatinine level at the time of admission to the intensive care unit (odds ratio 1.77 per mg/dL, 95% confidence interval 1.01–3.09; p = 0.045) was a mortality determinant. Out of the 33 patients, immunosuppressive agents were reduced in 17 (51.5%). We found that although immunosuppressant dose reduction tended to improve in-hospital mortality, this was not statistically significant. Nevertheless, during a mean follow-up period of two years, none of the survivors (n = 18) developed acute rejection or allograft necrosis.
CONCLUSION In RTRs with bacterial pneumonia and respiratory failure, higher serum creatinine levels were a mortality determinant. Although temporary immunosuppressant dose reduction might not reduce mortality, it was associated with a minimal risk of acute rejection during the two-year follow-up. Our results suggest that early immunosuppressant reduction in RTRs with severe pneumonia of indeterminate microbiology may be safe even when pathogens are bacterial in nature.
Keywords: immunosuppressant, kidney transplant, mortality, pneumonia, respiratory failure
Singapore Med J 2014; 55(7): 372-377; http://dx.doi.org/10.11622/smedj.2014089
REFERENCES
| 1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-30. http://dx.doi.org/10.1056/NEJM199912023412303 | ||||
| 2. Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000; 11:917-22. PMid:10770970 | ||||
| 3. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-14. http://dx.doi.org/10.1056/NEJMra064928 | ||||
| 4. Washer GF, Schroter GP, Starzl TE, Weil R, 3rd. Causes of death after kidney transplantation. JAMA 1983; 250:49-54. http://dx.doi.org/10.1001/jama.1983.03340010031024 | ||||
| 5. Candan S, Pirat A, Varol G, et al. Respiratory problems in renal transplant recipients admitted to intensive care during long-term follow-up. Transplant Proc 2006; 38:1354-6. http://dx.doi.org/10.1016/j.transproceed.2006.02.083 | ||||
| 6. Hoyo I, Linares L, Cervera C, et al. Epidemiology of pneumonia in kidney transplantation. Transplant Proc 2010; 42:2938-40. http://dx.doi.org/10.1016/j.transproceed.2010.07.082 | ||||
| 7. Fortun J, Martin-Davila P, Pascual J, et al. Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis 2010; 12:397-405. http://dx.doi.org/10.1111/j.1399-3062.2010.00526.x | ||||
| 8. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77:299-311. http://dx.doi.org/10.1038/ki.2009.377 | ||||
| 9. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416. http://dx.doi.org/10.1164/rccm.200405-644ST | ||||
| 10. Mandell LA, Wunderink RG, Anzueto A, Bar, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27-72. http://dx.doi.org/10.1086/511159 | ||||
| 11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29. http://dx.doi.org/10.1097/00003246-198510000-00009 | ||||
| 12. British Thoracic Society Standards of Care C. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001; 56 Suppl 4:IV1-64. http://dx.doi.org/10.1136/thx.56.suppl_4.iv1 | ||||
| 13. Canet E, Osman D, Lambert J, et al. Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care 2011; 15:R91. http://dx.doi.org/10.1186/cc10091 | ||||
| 14. James MT, Quan H, Tonelli M, et al. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009; 54:24-32. http://dx.doi.org/10.1053/j.ajkd.2009.04.005 | ||||
| 15. Viasus D, Garcia-Vidal C, Cruzado JM, et al. Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant 2011; 26:2899-906. http://dx.doi.org/10.1093/ndt/gfq798 | ||||
| 16. Kasiske BL, Israni AK, Snyder JJ, Skeans MA. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57:466-75. http://dx.doi.org/10.1053/j.ajkd.2010.10.054 | ||||
| 17. Eitner F, Hauser IA, Rettkowski O, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant 2011; 26:2013-7. http://dx.doi.org/10.1093/ndt/gfq689 | ||||
| 18. Aldawood A. The course and outcome of renal transplant recipients admitted to the intensive care unit at a tertiary hospital in Saudi Arabia. Saudi J Kidney Dis Transpl 2007; 18:536-40. PMid:17951939 | ||||
| 19. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57:307-13. http://dx.doi.org/10.1046/j.1523-1755.2000.00816.x | ||||
| 20. Stamm AM. Infection in organ-transplant recipients. N Engl J Med 1998; 339:1246. PMid:9786757 | ||||
| 21. Lindemann M, Heinemann FM, Horn PA, Witzke O. Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation 2010; 90:1463-7. http://dx.doi.org/10.1097/TP.0b013e3181f5d878 | ||||
| 22. Etienne I, Toupance O, Benichou J, et al. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits. Nephrol Dial Transplant 2010; 25:3096-106. http://dx.doi.org/10.1093/ndt/gfq135 | ||||
| 23. Watorek E, Szymczak M, Boratynska M, Patrzalek D, Klinger M. Cardiovascular risk in kidney transplant recipients receiving Mammalian target of rapamycin inhibitors. Transplant Proc 2011; 43:2967-9. http://dx.doi.org/10.1016/j.transproceed.2011.08.009 | ||||
| 24. Luan FL, Steffick DE, Ojo AO. Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int 2009; 76:825-30. http://dx.doi.org/10.1038/ki.2009.248 | ||||
| 25. Sileri P, Pursell KJ, Coady NT, et al. A standardized protocol for the treatment of severe pneumonia in kidney transplant recipients. Clin Transplant 2002; 16:450-4. http://dx.doi.org/10.1034/j.1399-0012.2002.02079.x | ||||
| 26. van de Wetering J, van der Mast BJ, de Kuiper P, et al. Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe. Transplant Proc 2005; 37:779-81. http://dx.doi.org/10.1016/j.transproceed.2004.11.061 | ||||
| 27. Li SH, Wang W, Hu XP, et al. Monitoring immune function after rapid corticosteroid reduction in kidney transplant recipients. Chin Med J (Engl) 2011; 124:679-82. | ||||
| 28. Klouche K, Amigues L, Massanet P, et al. Outcome of renal transplant recipients admitted to an intensive care unit: a 10-year cohort study. Transplantation 2009; 87:889-95. http://dx.doi.org/10.1097/TP.0b013e31819a688a | ||||
| 29. Kirilov D, Cohen J, Shapiro M, Grozovski E, Singer P. The course and outcome of renal transplant recipients admitted to a general intensive care unit. Transplant Proc 2003; 35:606. http://dx.doi.org/10.1016/S0041-1345(03)00007-1 | ||||
| 30. Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002; 2:970-4. http://dx.doi.org/10.1034/j.1600-6143.2002.21015.x | ||||
| 31. Polverino E, Torres A. Current perspective of the HCAP problem: is it CAP or is it HAP? Semin Respir Crit Care Med 2009; 30:239-48. http://dx.doi.org/10.1055/s-0029-1202940 | ||||